Remove topics controlled-substances-act
article thumbnail

Overview of the S. 3 landscape on patenting biotechnology inventions in India

SpicyIP

Unlike small molecule drugs, biologics are large and complex substances. Section 2(ja) of the Patents Act, 1970 defines an invention as a new product or process involving an inventive step and capable of industrial application and Section 3 specifies various bars to patent protection. In Asthristis Relied Plus Ltd.

article thumbnail

Journey Through “Augusts” on SpicyIP (2005 – Present)

SpicyIP

He wrote detailed posts on this topic later here and here. Talking about this topic, the issue of Judicial Recusals also shouldn’t be left untouched – an issue that has been the heart of several IP controversies, notably the Novartis dispute. The results revealed that the Ministry of Home Affairs had no source or backing of the data.

IP 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Patents & the Magical World of Psychedelics

IPilogue

Psilocybin, an active compound in what is commonly known as “magic mushrooms”, is currently listed under Schedule III of Canada’s Controlled Drugs and Substances Act. Under this Act , it is illegal to possess, obtain, or produce psilocybin without a prescription or licence. In 2020, the sales of cannabis products hit $2.6

Patent 59
article thumbnail

IP and Cannabis: The Current Landscape

Fish & Richardson Trademark & Copyright Thoughts

ii] While marijuana remains a Schedule I controlled substance under federal law, a majority of states have legalized consumption of certain cannabis products under certain conditions. Until 2018, cannabis in almost all of its forms was regulated as a Schedule I controlled substance – the same category used for heroin and LSD.

IP 52
article thumbnail

SpicyIP Weekly Review (February 26- March 3)

SpicyIP

Controller Gen of Patents: The DHC’s Dilemma of Identifying the Method of Treatment under Section 3(i) of the Patent Act In the context of Section 3(i), the DHC recently clarified that a ‘method of treatment’ is distinct from a ‘method of producing a substance’ that can later be used in the treatment.

article thumbnail

SpicyIP Weekly Review (July 26 – August 1)

SpicyIP

Topical Highlight. In Part I , I covered the suggested amendments to Section 3 of the Patents Act which concerns the exclusion of certain subject matters from patent protection. In a guest post , Shivam Kaushik discusses the copyrightability of fonts and typefaces from an artistic work perspective under the Copyright Act, 1957.

Reporting 116
article thumbnail

Does the First Amendment Permit Government Actors to Manage Social Media Comments?–Tanner v. Ziegenhorn

Technology & Marketing Law Blog

Tanner commented “this guy sucks,” but the post “contained no profanity, and it was on topic with the substance of the post.” “While not entirely on topic, this comment also abided by the page’s terms and conditions.” ” The court says: the agency acted against him for speaking.